Stay updated on rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the STARSCAPE clinical trial record, including its study design, eligibility criteria, locations, outcome measures, and supporting documents, instead of a 403 error screen.SummaryDifference100%

- Check11 days agoChange DetectedThe footer’s site revision label changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.3%

- Check25 days agoChange DetectedA new NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” while the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details. This indicates the study record is temporarily inaccessible and the content area displays an error screen.SummaryDifference16%

- Check60 days agoChange DetectedThe page's revision tag changed from Revision: v3.6.6 to Revision: v3.7.0. This indicates an update to the page's underlying version or template, rather than a substantive change to trial details or data displayed on the page.SummaryDifference0.0%

Stay in the know with updates to rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.